ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
다우존스 지수
39,069.59
0.01%
Bitcoin
69,995.70
2.17%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Crinetics Pharmaceuticals Inc (CRNX)

  7. Crinetics Pharmaceuticals Inc (CRNX) 뉴스

CRNX

Crinetics Pharmaceuticals (CRNX)

Crinetics Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CRNX
일자시간출처헤드라인심볼기업
2024/05/2221:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/05/1507:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/05/1105:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/05/1101:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/05/1005:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/05/1005:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/05/0906:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/05/0905:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/03/1205:15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/03/0710:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/03/0710:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/03/0710:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/03/0710:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/03/0709:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/03/0709:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/03/0206:41Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/02/2906:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/02/1506:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/02/1306:32Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/01/2707:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/01/2603:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/01/1306:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/01/1102:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/01/0822:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/01/0506:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/01/0506:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/01/0406:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2024/01/0306:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2023/12/2807:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
2023/12/2701:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:CRNX

최근 히스토리

EU
SNAQ
SNCF SNCF3.20%2JUN64
EU
3199T
3199T
KOSPI
001510
SK증권
COIN
CSPRKRW
Casper
EU
2403T
2403T
LSE
SD55
Nationwde.27 S
NYSE
HMA.WS
Heartland Media Acquisit...
COIN
KYFBTC
ASX
ADNNB
BIT
X74771
Natixis Structured Issua...
COIN
USDSPEUR
BIT
UI350X
UniCredit
COIN
FLPETH
Gameflip
LSE
PRFD
Inv Preferred
XE
DWD
Morgan Stanley
NASDAQ
BENEU
Benessere Capital Acquis...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유